Health TidingsFDA Accepts Lonafarnib NDA for Chronic Hepatitis D, Advancing Potential Fir... FDA Accepts Lonafarnib NDA for Chronic Hepatitis D, Advancing Potential Fir... Read Post »
Clinical TrialsJW Pharmaceutical’s Epaminurad 6 mg Shows Superiority Over Febuxostat... JW Pharmaceutical’s Epaminurad 6 mg Shows Superiority Over Febuxostat... Read Post »
Health Tidings Mergers & AcquisitionsSentynl Secures U.S. Option for Mereo’s Alvelestat Ahead of Phase 3 in AA... Sentynl Secures U.S. Option for Mereo’s Alvelestat Ahead of Phase 3 in AA... Read Post »
ResearchAfter 10-Year Clinical Outcomes, Penn Medicine Study Finds CD19 CAR T Cells... After 10-Year Clinical Outcomes, Penn Medicine Study Finds CD19 CAR T Cells... Read Post »
Health TidingsObinutuzumab β Reduces Relapse Risk by 93.1% in Phase 3 Trial of AQP4-IgG-... Obinutuzumab β Reduces Relapse Risk by 93.1% in Phase 3 Trial of AQP4-IgG-... Read Post »
Mergers & AcquisitionsJazz Pharmaceuticals to Acquire Actio Biosciences to Expand Rare Epilepsy P... Jazz Pharmaceuticals to Acquire Actio Biosciences to Expand Rare Epilepsy P... Read Post »
Health TidingsFDA Grants Fast Track Designation to AC Immune’s ACI-7104 for Parkinson D... FDA Grants Fast Track Designation to AC Immune’s ACI-7104 for Parkinson D... Read Post »
Clinical TrialsShattuck’s SL-325 Advances to Phase 2b in Crohn’s Disease with Durable ... Shattuck’s SL-325 Advances to Phase 2b in Crohn’s Disease with Durable ... Read Post »
Health TidingsVaderis Launches Phase 3 Trial of Engasertib in HHT After $152 Million Fund... Vaderis Launches Phase 3 Trial of Engasertib in HHT After $152 Million Fund... Read Post »
Clinical TrialsLZ901 Shows Strong Protection Against Herpes Zoster in Phase III Trial LZ901 Shows Strong Protection Against Herpes Zoster in Phase III Trial Read Post »
Health TidingsFDA Rejects ITM-11 NDA Over CMC and Facility Issues FDA Rejects ITM-11 NDA Over CMC and Facility Issues Read Post »
Clinical TrialsSilence’s Divesiran Meets Phase 2 Trial Endpoint in Polycythemia Vera Silence’s Divesiran Meets Phase 2 Trial Endpoint in Polycythemia Vera Read Post »
Health TidingsSoligenix Discontinues HyBryte Development After Phase 3 FLASH2 Trial Halte... Soligenix Discontinues HyBryte Development After Phase 3 FLASH2 Trial Halte... Read Post »
Health TidingsAquestive Reports Improved Human Factors and Comparable PK for Anaphylm Ahe... Aquestive Reports Improved Human Factors and Comparable PK for Anaphylm Ahe... Read Post »
Health TidingsSionna’s SION-719 Fails Phase 2a Sweat Chloride Endpoint in Cystic Fibros... Sionna’s SION-719 Fails Phase 2a Sweat Chloride Endpoint in Cystic Fibros... Read Post »
Clinical TrialsSonelokimab Delivers 42.1% ACR50 Response in Phase 3 Psoriatic Arthritis Tr... Sonelokimab Delivers 42.1% ACR50 Response in Phase 3 Psoriatic Arthritis Tr... Read Post »
Health Tidings Mergers & AcquisitionsSobi enters strategic partnership with Innate Pharma to license lacutamab i... Sobi enters strategic partnership with Innate Pharma to license lacutamab i... Read Post »
Health TidingsNicox Announces NCX 470 NDA Submission in China by Partner Ocumension Nicox Announces NCX 470 NDA Submission in China by Partner Ocumension Read Post »
Clinical TrialsTNX-103 Misses Primary Endpoint, Shows Benefit in More Severe PH-HFpEF TNX-103 Misses Primary Endpoint, Shows Benefit in More Severe PH-HFpEF Read Post »
Health Tidings Mergers & AcquisitionsBeOne, Revolution Medicines Expand RAS(ON) Cancer Collaboration in Asia BeOne, Revolution Medicines Expand RAS(ON) Cancer Collaboration in Asia Read Post »
Clinical TrialsAbCellera’s Phase 2 Data Position ABCL635 as a Potential New Approach to ... AbCellera’s Phase 2 Data Position ABCL635 as a Potential New Approach to ... Read Post »
ResearchInsilico Medicine Identifies NDRG1 as a New DNA Repair Target in Colorectal... Insilico Medicine Identifies NDRG1 as a New DNA Repair Target in Colorectal... Read Post »
Health TidingsRiboX Advances First-in-Class CAR-T Therapy Designed to Generate CAR-T Cell... RiboX Advances First-in-Class CAR-T Therapy Designed to Generate CAR-T Cell... Read Post »
New Drug ApprovalChina Approves Yochanra (Tinengotinib) for FGFR Inhibitor-Resistant Cholang... China Approves Yochanra (Tinengotinib) for FGFR Inhibitor-Resistant Cholang... Read Post »
Clinical TrialsAkeso Advances AK146D1 and Ivonescimab Combination in Breast Cancer Akeso Advances AK146D1 and Ivonescimab Combination in Breast Cancer Read Post »
Clinical TrialsBioMarin Stops BMN 401 Program After ENERGY 3 Trial Misses Key Endpoint BioMarin Stops BMN 401 Program After ENERGY 3 Trial Misses Key Endpoint Read Post »
Health TidingsBioInvent’s BI-1808 Wins FDA Fast Track Designation for Ovarian Cancer BioInvent’s BI-1808 Wins FDA Fast Track Designation for Ovarian Cancer Read Post »
ResearchHigh-Dose Vitamin D3 Does Not Improve Progression-Free Survival in Metastat... High-Dose Vitamin D3 Does Not Improve Progression-Free Survival in Metastat... Read Post »
Health TidingsVedanta Biosciences Secures $60 Million to Advance Phase 3 VE303 Trial for ... Vedanta Biosciences Secures $60 Million to Advance Phase 3 VE303 Trial for ... Read Post »
Health TidingsNeurocrine Biosciences Advances Triple Receptor Obesity Therapy NBIP-‘... Neurocrine Biosciences Advances Triple Receptor Obesity Therapy NBIP-‘... Read Post »
New Drug ApprovalMHRA Authorises Rhapsido (Remibrutinib) for Adults with Chronic Spontaneous... MHRA Authorises Rhapsido (Remibrutinib) for Adults with Chronic Spontaneous... Read Post »
Clinical TrialsPepGen Advances PGN-EDODM1 in Phase 2 DM1 Trial After DSMB Review PepGen Advances PGN-EDODM1 in Phase 2 DM1 Trial After DSMB Review Read Post »
Drugs Safety AlertEuropean Commission Revokes TAVNEOS EU Approval for ANCA Vasculitis European Commission Revokes TAVNEOS EU Approval for ANCA Vasculitis Read Post »
Health Tidings Mergers & AcquisitionsEvotec, Odyssey Partner to Advance AI-Driven Small Molecule Discovery for A... Evotec, Odyssey Partner to Advance AI-Driven Small Molecule Discovery for A... Read Post »
Clinical TrialsDouble-Shot Fasedienol Nasal Spray Shows Promise in Reducing Social Anxiety Double-Shot Fasedienol Nasal Spray Shows Promise in Reducing Social Anxiety Read Post »
Health Tidings Mergers & AcquisitionsOno and Mediar Partner to Develop Novel Antibody Therapies for Fibrosis Ono and Mediar Partner to Develop Novel Antibody Therapies for Fibrosis Read Post »
New Drug ApprovalFDA Approves TUDRIQEV: First Oncolytic Viral Immunotherapy for PD-1-Refract... FDA Approves TUDRIQEV: First Oncolytic Viral Immunotherapy for PD-1-Refract... Read Post »
ResearchNew Nature Study Finds Dronabinol Reduced Trauma-Related Nightmares New Nature Study Finds Dronabinol Reduced Trauma-Related Nightmares Read Post »
Clinical TrialsPharvaris Study Validates Patient-Reported Outcomes for Rare Acquired Angio... Pharvaris Study Validates Patient-Reported Outcomes for Rare Acquired Angio... Read Post »
Health TidingsDutch Court Grants Novo Nordisk Preliminary Injunction Against Compounded S... Dutch Court Grants Novo Nordisk Preliminary Injunction Against Compounded S... Read Post »
Health TidingsNICE Recommends Acalabrutinib-Based Regimens as New First-Line Options for ... NICE Recommends Acalabrutinib-Based Regimens as New First-Line Options for ... Read Post »
Clinical TrialsPacira PCRX-201 Shows Durable 2-Year Benefit in Knee Osteoarthritis Trial Pacira PCRX-201 Shows Durable 2-Year Benefit in Knee Osteoarthritis Trial Read Post »
Clinical TrialsBioVie Reports Positive SUNRISE-PD Trial Results for Bezisterim BioVie Reports Positive SUNRISE-PD Trial Results for Bezisterim Read Post »
Health TidingsMerck Wins FDA Review for ENFLONSIA Expansion in High-Risk Children Merck Wins FDA Review for ENFLONSIA Expansion in High-Risk Children Read Post »
New Drug ApprovalModerna Wins FDA Approval for First mRNA Flu Vaccine mFLUSIVA Moderna Wins FDA Approval for First mRNA Flu Vaccine mFLUSIVA Read Post »
Health TidingsFDA Approves Takeda’s ORZEYFUL, the First Orexin Therapy for Adults with ... FDA Approves Takeda’s ORZEYFUL, the First Orexin Therapy for Adults with ... Read Post »
Clinical TrialsFridge-Free Tetanus-Diphtheria Vaccine Marks Milestone for Vaccine Science Fridge-Free Tetanus-Diphtheria Vaccine Marks Milestone for Vaccine Science Read Post »
Health TidingsIs Sustained Calorie Reduction the Key to Semaglutide’s Long-Term Wei... Is Sustained Calorie Reduction the Key to Semaglutide’s Long-Term Wei... Read Post »
Health TidingsSummit Launches HARMONi-GU1 Trial of Ivonescimab for First-Line Advanced Bl... Summit Launches HARMONi-GU1 Trial of Ivonescimab for First-Line Advanced Bl... Read Post »
Clinical TrialsClarity Reports Strong Disease Control With 67Cu-SAR-bisPSMA in Phase I/IIa... Clarity Reports Strong Disease Control With 67Cu-SAR-bisPSMA in Phase I/IIa... Read Post »
